Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:34 pm Purchase |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 3,137,553 4.990% |
773,553 (+32.72%) |
Filing History |
| 2025-02-14 11:22 am Sale |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Frazier Life Sciences Public Fund, L.P. | 1,176,735 2.000% |
-2,384,909 (-66.96%) |
Filing History |
| 2024-11-14 4:51 pm Sale |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 2,364,000 5.960% |
-78,742 (-3.22%) |
Filing History |
| 2024-11-05 4:17 pm Purchase |
2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
RA Capital Management, L.P. | 3,566,338 6.100% |
3,566,338 (New Position) |
Filing History |
| 2024-11-05 11:44 am Purchase |
2024-10-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Frazier Life Sciences Public Fund, L.P. | 3,561,644 6.100% |
3,561,644 (New Position) |
Filing History |
| 2024-10-31 5:50 pm Unchanged |
2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 10.500% |
0 (Unchanged) |
Filing History |
| 2024-10-31 5:49 pm Purchase |
2024-09-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 6,293,282 15.900% |
1,966,572 (+45.45%) |
Filing History |
| 2024-02-14 3:35 pm Purchase |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Armistice Capital, LLC | 2,442,742 9.990% |
2,442,742 (New Position) |
Filing History |
| 2024-02-14 3:01 pm Unchanged |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Cormorant Asset Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 10:06 am Purchase |
2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 4,326,710 17.900% |
2,000,000 (+85.96%) |
Filing History |
| 2023-02-14 3:00 pm Sale |
2022-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Cormorant Asset Management LP | 1,391,663 9.990% |
-36,935 (-2.59%) |
Filing History |
| 2022-02-14 3:00 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Cormorant Asset Management LP | 1,428,598 9.900% |
1,428,598 (New Position) |
Filing History |
| 2022-02-11 07:20 am Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Woodline Partners LP | 685,273 4.800% |
685,273 (New Position) |
Filing History |
| 2022-02-10 09:01 am Unchanged |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
FMR CORP | 504,371 3.525% |
504,371 (New Position) |
Filing History |
| 2022-01-28 4:35 pm Purchase |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 2,326,710 16.900% |
878,690 (+60.68%) |
Filing History |
| 2022-01-26 4:27 pm Sale |
2022-01-20 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 0 0.000% |
-1,339,793 (Position Closed) |
Filing History |
| 2022-01-10 5:57 pm Purchase |
2022-01-06 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,448,020 10.100% |
13,088 (+0.91%) |
Filing History |
| 2022-01-10 5:51 pm Purchase |
2021-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
BIOTECHNOLOGY VALUE FUND L P | 1,434,932 9.990% |
1,434,932 (New Position) |
Filing History |
| 2021-09-09 12:30 pm Purchase |
2020-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Logos Global Management LP | 1,339,793 9.400% |
1,339,793 (New Position) |
Filing History |